BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 37406390)

  • 1. Ginsenoside Rh2: A shining and potential natural product in the treatment of human nonmalignant and malignant diseases in the near future.
    Guan W; Qi W
    Phytomedicine; 2023 Sep; 118():154938. PubMed ID: 37406390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer property of ginsenoside Rh2 from ginseng.
    Li X; Chu S; Lin M; Gao Y; Liu Y; Yang S; Zhou X; Zhang Y; Hu Y; Wang H; Chen N
    Eur J Med Chem; 2020 Oct; 203():112627. PubMed ID: 32702586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ginsenoside 20(S)-Rh2 exerts anti-cancer activity through targeting IL-6-induced JAK2/STAT3 pathway in human colorectal cancer cells.
    Han S; Jeong AJ; Yang H; Bin Kang K; Lee H; Yi EH; Kim BH; Cho CH; Chung JW; Sung SH; Ye SK
    J Ethnopharmacol; 2016 Dec; 194():83-90. PubMed ID: 27566200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer Effects of Ginsenoside Rh2: A Systematic Review.
    He XL; Xu XH; Shi JJ; Huang M; Wang Y; Chen X; Lu JJ
    Curr Mol Pharmacol; 2022; 15(1):179-189. PubMed ID: 33687905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumoral Activity of (20R)- and (20S)-Ginsenoside Rh2 on Transplanted Hepatocellular Carcinoma in Mice.
    Lv Q; Rong N; Liu LJ; Xu XL; Liu JT; Jin FX; Wang CM
    Planta Med; 2016 May; 82(8):705-11. PubMed ID: 27163230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and bioactivity of the rare ginsenosides Rg3 and Rh2: An updated review.
    Xu W; Lyu W; Duan C; Ma F; Li X; Li D
    Fitoterapia; 2023 Jun; 167():105514. PubMed ID: 37084851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in Biocatalytic Synthesis, Pharmacological Activities, Pharmaceutical Preparation and Metabolism of Ginsenoside Rh2.
    Liu L; Wang H; Chai X; Meng Q; Jiang S; Zhao F
    Mini Rev Med Chem; 2022; 22(3):437-448. PubMed ID: 34517798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of ginsenoside Rh2 in tumor therapy and tumor microenvironment immunomodulation.
    Xiaodan S; Ying C
    Biomed Pharmacother; 2022 Dec; 156():113912. PubMed ID: 36288668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticancer effects and potential mechanisms of ginsenoside Rh2 in various cancer types (Review).
    Zhang H; Park S; Huang H; Kim E; Yi J; Choi SK; Ryoo Z; Kim M
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ginsenoside Rh2 Targets EGFR by Up-Regulation of miR-491 to Enhance Anti-tumor Activity in Hepatitis B Virus-Related Hepatocellular Carcinoma.
    Chen W; Qiu Y
    Cell Biochem Biophys; 2015 Jun; 72(2):325-31. PubMed ID: 25561284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic studies on protopanaxadiol, Rh2, and ginseng (Panax quinquefolius) extract induced cytotoxicity in intestinal Caco-2 cells.
    Popovich DG; Kitts DD
    J Biochem Mol Toxicol; 2004; 18(3):143-9. PubMed ID: 15252870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of a New Ginsenoside Rh2 Nanoniosomal Formulation for Enhanced Antitumor Efficacy on Prostate Cancer: An in vitro Study.
    Zare-Zardini H; Alemi A; Taheri-Kafrani A; Hosseini SA; Soltaninejad H; Hamidieh AA; Haghi Karamallah M; Farrokhifar M; Farrokhifar M
    Drug Des Devel Ther; 2020; 14():3315-3324. PubMed ID: 32884236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Induction of differentiation by ginsenoside Rh2 in hepatocarcinoma cell SMMC-7721].
    Zeng XL; Tu ZG
    Ai Zheng; 2004 Aug; 23(8):879-84. PubMed ID: 15301707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ginsenoside Rd: A promising natural neuroprotective agent.
    Chen YY; Liu QP; An P; Jia M; Luan X; Tang JY; Zhang H
    Phytomedicine; 2022 Jan; 95():153883. PubMed ID: 34952508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ginsenoside Rh2 is one of the active principles of Panax ginseng root to improve insulin sensitivity in fructose-rich chow-fed rats.
    Lee WK; Kao ST; Liu IM; Cheng JT
    Horm Metab Res; 2007 May; 39(5):347-54. PubMed ID: 17533576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ginsenoside Rh2 reduces ischemic brain injury in rats.
    Park EK; Choo MK; Oh JK; Ryu JH; Kim DH
    Biol Pharm Bull; 2004 Mar; 27(3):433-6. PubMed ID: 14993818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereospecificity of hydroxyl group at C-20 in antiproliferative action of ginsenoside Rh2 on prostate cancer cells.
    Liu J; Shimizu K; Yu H; Zhang C; Jin F; Kondo R
    Fitoterapia; 2010 Oct; 81(7):902-5. PubMed ID: 20554003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of ginsenosides Rg3 and Rh2 from North American ginseng.
    Popovich DG; Kitts DD
    Phytochemistry; 2004 Feb; 65(3):337-44. PubMed ID: 14751305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 20(S)-Ginsenoside Rh2 as aldose reductase inhibitor from Panax ginseng.
    Fatmawati S; Ersam T; Yu H; Zhang C; Jin F; Shimizu K
    Bioorg Med Chem Lett; 2014 Sep; 24(18):4407-4409. PubMed ID: 25152999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMP-activated protein kinase determines apoptotic sensitivity of cancer cells to ginsenoside-Rh2.
    Kim MJ; Yun H; Kim DH; Kang I; Choe W; Kim SS; Ha J
    J Ginseng Res; 2014 Jan; 38(1):16-21. PubMed ID: 24558305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.